Szostak, B., Kułaga, M., Kasprzak, A., Grzybek, M., Mazur-Lesińska, D., Wielgosz-Biała, S., … Wilczyńska, B. (2025). Overview of available treatment and new drug action points in obesity pharmacology. Will GIP, glucagon, amylin replace GLP-1?. Prospects in Pharmaceutical Sciences, 23(2), 42–49. https://doi.org/10.56782/pps.361